Department of Clinical Pharmacology and Therapeutics, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Clin Pharmacol Ther. 2013 Dec;94(6):702-8. doi: 10.1038/clpt.2013.167. Epub 2013 Aug 23.
Cytochrome P450 (CYP) 1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A are major factors involved in the metabolism of clinically prescribed drugs. Because the time course after drug treatment discontinuation has received little attention, we aimed to clarify the chronological changes of rifampicin-induced CYP enzyme activities after rifampicin discontinuation. Thirteen volunteers took 450 mg of rifampicin once daily, and the cocktail method, which uses caffeine, losartan, omeprazole, dextromethorphan, and midazolam as CYP-specific probes, was repeatedly used for the evaluation of CYP levels. Concentrations of probes and metabolites were determined by liquid chromatography-tandem mass spectrometry. Seven-day rifampicin administration increased CYP2C19 and CYP3A enzyme activities. The induced CYP2C19 and CYP3A activities remained elevated at 4 days after rifampicin discontinuation and returned to baseline levels 8 days after rifampicin discontinuation. CYP1A2 and CYP2D6 enzyme activities showed no significant changes, and CYP2C9 enzyme activity was increased with rifampicin administration, with a tendency toward statistical significance. Drug interactions can occur even after rifampicin discontinuation.
细胞色素 P450(CYP)1A2、CYP2C9、CYP2C19、CYP2D6 和 CYP3A 是参与临床处方药物代谢的主要因素。由于停药后药物代谢的时间过程尚未得到充分关注,我们旨在阐明利福平停药后利福平诱导的 CYP 酶活性的时间变化。13 名志愿者每天服用 450mg 利福平,重复使用咖啡因、洛沙坦、奥美拉唑、右美沙芬和咪达唑仑作为 CYP 特异性探针的鸡尾酒方法评估 CYP 水平。通过液相色谱-串联质谱法测定探针和代谢物的浓度。7 天的利福平给药增加了 CYP2C19 和 CYP3A 酶活性。利福平停药后 4 天诱导的 CYP2C19 和 CYP3A 活性仍升高,停药后 8 天恢复基线水平。CYP1A2 和 CYP2D6 酶活性无明显变化,CYP2C9 酶活性随利福平给药而增加,有统计学意义的趋势。即使在利福平停药后,仍可能发生药物相互作用。